Boardroom Alpha
Start trial
10-K primary document
XTNT · Annual Report (Form 10-K) · Filed March 31, 2026

Xtant Medical Holdings Inc — 10-K exhibit

ex10-37.htm
Xtant Medical Holdings Inc on Boardroom Alpha

 

Exhibit 10.37

 

ADDENDUM TO COMMERCIAL LEASE BETWEEN

CRUISER LANE LLC & XTANT MEDICAL, INC.

 

Dated September 8, 2025

 

The parties to this Addendum to Commercial Lease are Cruiser Lane, LLC (hereinafter known as Landlord) and Xtant Medical, Inc., (referred to as Tenant). This document serves as an Addendum to the collective Commercial Lease and supporting documents (effective February 1, 2012) and the subsequent lease renewal, dated July 1, 2022.

 

The parties have agreed to renew the current lease agreement terminating October 31, 2025 and will execute the new addendum herein.

 

1.Term: As permitted through mutual agreement of both parties, the new term of said lease shall be a period of five (5) years.
  
2.Renewal option: At the end of the five-year term, Tenant has the option to renew said lease for two additional five-year terms. Landlord, at that time, has the option to renegotiate lease rates.
  
3.Rents: The rental rate shall adjust as outlined in the table below through the first five-year term beginning November 1, 2025 and adjusting on November 1 of the applicable year.

 

Year 1  (11/1/2025 – 10/31/2026) $ 14.50 / SF
Year 2  (11/1/2026 – 10/31/2027) $ 15.00 / SF
Year 3  (11/1/2027 – 10/31/2028) $ 15.00 / SF
Year 4  (11/1/2028 – 10/31/2029) $ 15.50 / SF
Year 5  (11/1/2029 – 10/31/2030) $ 15.50 / SF

 

4.All other terms and addendums of the original contract of 2012 remain in full force and effect.

 

Signed and Dated:

 

/s/ Ronald R. Pierzina   Date: 9-11-2025
Ronald R. Pierzina      
Managing Partner      
Cruiser Lane, LLC      
       
/s/ Laura J Pierzina   Date: 9-11-2025
Laura J Pierzina      
Managing Partner      
Cruiser Lane, LLC      
       
/s/ Scott Neils   Date: 09/08/2025
Scott Neils      
Chief Financial Officer      
Xtant Medical, Inc.      

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer